Hypothalamic Circuits Responsive to Ghrelin: Regulation by Leptin and Insulin

  • S. L. Dickson
  • L. Y. C. Tung
  • A. K. Hewson
Conference paper


Since its discovery in 1999 (Kojima et al., 1999), ghrelin has emerged as a potentially important circulating hunger-inducing peptide (Wren et al., 2001a; Cummings et al., 2001). It was isolated from the oxyntic glands of the rat stomach (Kojima et al., 1999) and this appears to be the major source of circulating ghrelin as levels are reduced by 80% following gastrectomy (Dordonville de la Cour et al., 2001). Ghrelin mRNA has also been detected in a number of other organs, including the pituitary (Korbonits et al., 2001), hypothalamus (Kojima et al., 1999), kidney (Mori et al., 2000), bowel (Date et al., 2000) and placenta (Gualillo et al., 2001).


Anorexia Nervosa Ghrelin Level Arcuate Nucleus Negative Energy Balance Plasma Ghrelin Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baskin D.G., Lattemann D.E, Seeley R.J., Woods S.C., Porte D. and Schwartz M.W. (1999). Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res, 848, 114–123.PubMedCrossRefGoogle Scholar
  2. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., Wren A.M., Brynes A.E., Low M.J., Ghatei M.A., Cone R.D. and Bloom S.R. (2002). Gut hormone PYY3-36 physiologically inhibits food intake. Nature, 418, 650–654.PubMedCrossRefGoogle Scholar
  3. Bowers C.Y., Momany F.A., Reynolds G.A. and Hong A. (1984). On the in vitro and in vivo act ivity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth-hormone. Endocrinology, 114, 1537–1545.PubMedCrossRefGoogle Scholar
  4. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E. and Weigle D.S. (2001). Apreprandial rise in plasma ghrelin levels suggests a role in meal init iation in humans. Diabetes, 50, 1714–1719.PubMedCrossRefGoogle Scholar
  5. Cusin I., Rohner Jeanrenaud E, Stricker Krongrad A. and Jeanrenaud B. (1996). The weight-reducing effect of an intracerebroventricular bolus injection ofleptin in genetically Obese fa/fa rats-reduced sensitivity compared with lean animals. Diabetes, 45, 1446–1451.PubMedCrossRefGoogle Scholar
  6. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., Matsukura S., Kangawa K. and Nakazato M. (2000). Ghrelin, a novel growth hormone-releasing acy lated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology, 141, 4255–4261.PubMedCrossRefGoogle Scholar
  7. Dickson S.L., Leng G., Dyball R.E.J, and Smith R.G. (1995). Central actions of peptide and nonpeptide growth-hormone secretagogues in the rat. Neuroendocrinology, 61, 36–43.PubMedCrossRefGoogle Scholar
  8. Dickson S.L., Leng G. and Robinson I.C.A.F. (1993). Growth-hormone release evoked by electrical-stimulation of the arcuate nucleus in anesthetized male-rats. Brain Res, 623, 95–100.PubMedCrossRefGoogle Scholar
  9. Dickson S.L. and Luckman S.M. (1997). Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide 6. Endocrinology, 138, 771–777.PubMedCrossRefGoogle Scholar
  10. Dordonville De la Cour C.D., Bjorkqvist M., Sandvik A.K., Bakke I., Zhao C.M., Chen D. and Hakanson R. (2001). A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Reg Peptides, 99, 141–150.CrossRefGoogle Scholar
  11. Friedman J.M. (2000). Obesity in the new millennium. Nature, 404, 632-634.PubMedGoogle Scholar
  12. Gualillo O., Caminos J.E., Blanco M., Garcia-Caballero T., Kojima M., Kangawa K., Dieguez C and Casanueva F.F. (2001). Ghrelin, a novel placental-derived hormone. Endocrinology, 142,788-794.PubMedCrossRefGoogle Scholar
  13. Hahn T.M., Breininger J.F., Baskin D.G. and Schwartz M.W. (1998). Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nature Neurosci, 1, 271–272.PubMedCrossRefGoogle Scholar
  14. Hewson A.K. and Dickson S.L. (2000). Systemic administration of ghrelin induces Fos and Egr-i proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol, 12, 1047–1049.PubMedCrossRefGoogle Scholar
  15. Hewson A.K., Tung L.Y.C, Connell D.W., Tookman L. and Dickson S.L. (2002). The rat arcuate nucleus integrates peripheral signals provided by leptin, insulin and a ghrelin mimetic. Diabetes, 51, 3412–3419.PubMedCrossRefGoogle Scholar
  16. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum CL, Hamelin M., Hreniuk D.L., Palyha O.C, Anderson J., Paress P.S., Diaz C, Chou M., Liu K.K., Mckee K.K., Pong S.S., Chaung L.Y., Elbrecht A., Dashkevicz M., Heavens R., Rigby M., Sirinathsinghji D.J.S., Dean D.C., Melillo D.G., Patchett A.A., Nargund R., Griffin P.R., DeMartino J.A., Gupta S.K., Schaeffer J.M., Smith R.G. and Van der Ploeg L.H.T. (1996). A receptor in pituitary and hypothalamus that functions in growth hormone release. Science, 273, 974–977.PubMedCrossRefGoogle Scholar
  17. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H. and Wakabayashi I. (2001). Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and agouti-related protein mRNA levels and body weight in rats. Diabetes, 50, 2438–2443.PubMedCrossRefGoogle Scholar
  18. Kojima M., Hosoda H., Date Y, Nakazato M., Matsuo H. and Kangawa K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656–660.PubMedCrossRefGoogle Scholar
  19. Korbonits M., Kojima M., Kangawa K. and Grossman A.B. (2001). Presence of ghrelin in normal and adenomatous human pituitary. Endocrine, 14, 101–104.PubMedCrossRefGoogle Scholar
  20. Lall S., Tung L.Y.C., Ohlsson C., Jansson J.O. and Dickson S.L. (2001). Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochem Biophys Res Commun, 280,132–138.PubMedCrossRefGoogle Scholar
  21. Lu D.S., Willard D., Patel I.R., Kadwell S., Overton L., Kost T., Luther M., Chen W.B., Woychik R.P., Wilkison W.O. and Cone R.D. (1994). Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature, 371, 799–802.PubMedCrossRefGoogle Scholar
  22. Luckman S.M., Rosenzweig I. and Dickson S.L. (1999). Activation of arcuate nucleus neurons by systemic administration of leptin and growth hormone-releasing peptide-6 in normal and fasted rats. Neuroendocrinology, 70, 93–100.PubMedCrossRefGoogle Scholar
  23. Marks J.L., Waite K. and Li M. (1993). Effects of streptozotocin-induced diabetes-mellitus and insulin-treatment on neuropeptide- Y messenger RNA in the rat hypothalamus. Diabetologia, 36,497-502.PubMedCrossRefGoogle Scholar
  24. Mori K., Yoshimoto A., Takaya K., Hosoda K., Ariyasu H., Yahata K., Mukoyama M., Sugawara A., Hosoda H., Kojima M., Kangawa K. and Nakao K. (2000). Kidney produces a novel acylated peptide, ghrelin. Febs Lett, 486, 213–216.PubMedCrossRefGoogle Scholar
  25. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K. and Matsukura S. (2001). A role for ghrelin in the central regulation of feeding. Nature, 409, 194–198.PubMedCrossRefGoogle Scholar
  26. Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R.L., Heiman M.L., Lehnert R., Fichter M. and Tschop M. (2001). Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol, 145, R5–R9.Google Scholar
  27. Schwartz M.W., Marks J.L., Sipols A.J., Baskin D.G., Woods S.C., Kahn S.E. and Porte D. (1991). Central insulin administration reduces neuropeptide- Y messenger RNA expression in the arcuate nucleus of food-deprived lean (fa/fa) but not obese (fa/fa) zucker rats. Endocrinology, 128, 2645–2647.PubMedCrossRefGoogle Scholar
  28. Schwartz M.W., Sipols A.J., Marks J.L., Sanacora G., White J.D., Scheurink A., Kahn S.E., Baskin D.G., Woods S.C., Figlewicz D.P. and Porte D. (1992). Inhibition of hypothalamic neuropeptide- Y gene-expression by insulin. Endocrinology, 130, 3608–3616.PubMedCrossRefGoogle Scholar
  29. Shintani M., Ogawa Y., Ebihara K., Aizawa-Abe M., Miyanaga F., Takaya K., Hosoda K., Hayashi T., Inoue G., Kojima M., Kangawa K. and Nakao K. (2001). Ghrelin is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic NeuropeptideY/Yi pathway. Diabetes, 50, A15.CrossRefGoogle Scholar
  30. Stephens T.W., Basinski M., Bristow P.K., Buevalleskey J.M., Burgett S.G., Craft L., Hale J., Hoffmann J., Hsiung H.M., Kriauciunas A., Mackellar W., Rosteck R.R., Schoner B., Smith D., Tinsley F.C., Zhang X.Y. and Heiman M. (1995). The role of neuropeptide-Y in the antiobesity action of the obese gene-product. Nature, 377, 530–532.PubMedCrossRefGoogle Scholar
  31. Tannenbaum G.S. and Bowers C.Y. (2001). Interactions of growth hormone secreta-gogues and growth hormone-releasing hormone/somatostatin. Endocrine 14, 21–27.PubMedCrossRefGoogle Scholar
  32. Tschöp M., Smiley D.L. and Heiman M.L. (2000). Ghrelin induces adiposity in rodents. Nature, 407,908–913.PubMedCrossRefGoogle Scholar
  33. Tschöp M., Statnick M.A., Suter T.M. and Heiman M.L. (2002). GH-releasing peptide-2 increases fat mass in mice lacking NPY: Indication for a crucial mediating role of hypothalamic agouti- related protein. Endocrinology, 143, 558–568.PubMedCrossRefGoogle Scholar
  34. Tschöp M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E. and Heiman M.L. (2001). Circulating Ghrelin levels are decreased in human obesity. Diabetes, 50, 707–709.PubMedCrossRefGoogle Scholar
  35. Tung Y.C.L., Hewson A.K. and Dickson S.L. (2001). Actions of leptin on growth hormone secretagogue-responsive neurones in the rat hypothalamic arcuate nucleus recorded in vitro. J Neuroendocrinol, 13, 209–215.PubMedCrossRefGoogle Scholar
  36. Willesen M.G., Kristensen P. and Romer J. (1999). Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology, 70, 306–316.PubMedCrossRefGoogle Scholar
  37. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo WS., Ghatei M.A. and Bloom S.R. (2001a). Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab, 86, 5992–5995.CrossRefGoogle Scholar
  38. Wren A.M., Small C.J., Abbott C.R., Dhillo WS., Seal L.J., Cohen M.A., Batterham R.L., Taheri S., Stanley S.A., Ghatei M.A. and Bloom S.R. (2001b). Ghrelin causes hyper-phagia and obesity in rats. Diabetes, 50, 2540–2547.CrossRefGoogle Scholar
  39. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., Kennedy A.R., Roberts G.H., Morgan D.G.A., Ghatei M.A. and Bloom S.R. (2000). The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology, 141, 4325–4328.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • S. L. Dickson
  • L. Y. C. Tung
  • A. K. Hewson

There are no affiliations available

Personalised recommendations